Pages that link to "Q29615607"
Jump to navigation
Jump to search
The following pages link to Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma (Q29615607):
Displaying 50 items.
- Glioblastoma formation from cell population depleted of Prominin1-expressing cells (Q21091187) (← links)
- CD133 antigen expression in ovarian cancer (Q21093306) (← links)
- MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1 (Q21245764) (← links)
- Salinomycin as a drug for targeting human cancer stem cells (Q21285139) (← links)
- Regulation of myeloid leukaemia by the cell-fate determinant Musashi (Q24634359) (← links)
- Human embryonic and neuronal stem cell markers in retinoblastoma (Q24647640) (← links)
- Prostate cancer stem cells (Q24654712) (← links)
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy (Q26740207) (← links)
- Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds (Q26747518) (← links)
- Cancer Stem Cell Hierarchy in Glioblastoma Multiforme (Q26752312) (← links)
- New Insights into the Crossroads between EMT and Stemness in the Context of Cancer (Q26764831) (← links)
- Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets (Q26765758) (← links)
- Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy (Q26772300) (← links)
- Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance (Q26775006) (← links)
- Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma (Q26776219) (← links)
- Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2 (Q26777988) (← links)
- Cancer stem cell targeted therapy: progress amid controversies. (Q26779931) (← links)
- Therapy escape mechanisms in the malignant prostate (Q26795611) (← links)
- Targeting Aggressive Cancer Stem Cells in Glioblastoma (Q26799983) (← links)
- Harnessing the apoptotic programs in cancer stem-like cells (Q26801037) (← links)
- Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers (Q26822406) (← links)
- Cancer stem cells--important players in tumor therapy resistance (Q26823015) (← links)
- G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues (Q26825769) (← links)
- Current vaccine trials in glioblastoma: a review (Q26828965) (← links)
- Twisted tango: brain tumor neurovascular interactions (Q26849613) (← links)
- Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention (Q26850218) (← links)
- Salinomycin: a novel anti-cancer agent with known anti-coccidial activities (Q26853644) (← links)
- Glioblastoma cancer stem cells: Biomarker and therapeutic advances (Q26859782) (← links)
- MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells (Q26865287) (← links)
- Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies (Q26995698) (← links)
- Brain tumor stem cells: Molecular characteristics and their impact on therapy (Q27003138) (← links)
- Novel delivery strategies for glioblastoma (Q27006099) (← links)
- Immunotherapy for brain cancer: recent progress and future promise (Q27015881) (← links)
- Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer (Q27022633) (← links)
- Targeting glioma stem cells: A novel framework for brain tumors (Q27026818) (← links)
- Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia (Q27309004) (← links)
- Imaging proteolytic activity in live cells and animal models (Q27314960) (← links)
- Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells (Q27320024) (← links)
- Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells (Q27335770) (← links)
- High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma (Q27852569) (← links)
- Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells (Q28072067) (← links)
- Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death (Q28080874) (← links)
- SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma (Q28244307) (← links)
- Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells (Q28257733) (← links)
- Exploring the role of cancer stem cells in radioresistance (Q28282037) (← links)
- Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells (Q28473082) (← links)
- T cells enhance stem-like properties and conditional malignancy in gliomas (Q28474262) (← links)
- Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus (Q28474594) (← links)
- Phosphoproteome of human glioblastoma initiating cells reveals novel signaling regulators encoded by the transcriptome (Q28482324) (← links)
- Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels (Q28484532) (← links)